Figure 2.
Therapeutic strategies targeting CD133 in HCC, including antibodies, aptamers, CAR T cells, oncolytic viruses and some drugs or compounds
Therapeutic strategies targeting CD133 in HCC, including antibodies, aptamers, CAR T cells, oncolytic viruses and some drugs or compounds